943 studies found for:    "Osteoporosis"
Show Display Options
Rank Status Study
21 Completed TOP: Trial of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
Condition: Osteoporosis
Intervention: Drug: ALX1-11
22 Completed A Double Blind, Placebo Controlled, Parallel-Group Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis
Condition: Osteoporosis
Intervention: Drug: ALX1-11
23 Completed Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women
Condition: Osteoporosis
Intervention: Drug: Bazedoxifene Acetate (TSE-424)
24 Unknown  Multi-joint Coordination Underlies Upright Balance Control in Elderly With Osteoporosis
Condition: Osteoporosis
Intervention:
25 Enrolling by invitation Teriparatide Treatment in Patients With Inherited Osteoporosis
Condition: Osteoporosis
Intervention: Drug: Teriparatide
26 Completed
Has Results
Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: AMG 162;   Drug: Placebo
27 Completed Study of Investigational Drug in Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: MK0217, alendronate sodium/Duration of Treatment: 3 months;   Drug: Comparator: placebo / Duration of Treatment: 3 months
28 Completed Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis
Conditions: Postmenopausal Osteoporosis;   Compliance
Interventions: Drug: Raloxifene;   Drug: Strontium ranelate
29 Unknown  Osteoporosis Coordinator for Low Volume Community Hospitals
Conditions: Osteoporosis;   Fragility Fractures
Interventions: Behavioral: centralized osteoporosis coordinator;   Behavioral: fall prevention
30 Completed Education for Osteoporosis in Persons With Existing Fractures
Condition: Osteoporosis
Interventions: Behavioral: Osteoporosis Prevention and Self-Management Course;   Behavioral: Introductory education session on osteoporosis
31 Unknown  Vitamin K as Additive Treatment in Osteoporosis
Condition: Post-Menopausal Osteoporosis
Interventions: Drug: Phylloquinone;   Drug: Menaquinone (MK4);   Drug: placebo
32 Completed
Has Results
Double-blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis)
Condition: Osteoporosis
Interventions: Drug: Zoledronic Acid;   Drug: Placebo
33 Completed Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: Recombinant Salmon Calcitonin
34 Active, not recruiting A Randomized Phase 3 Study to Evaluate 2 Different Formulations of Romosozumab in Postmenopausal Women With Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Romosozumab;   Drug: Placebo
35 Completed Combination Osteogenic Therapy in Established Osteoporosis
Condition: Osteoporosis, Post-Menopausal
Interventions: Drug: PTH 1-34;   Drug: MFPSR-fluoride
36 Enrolling by invitation Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Intervention: Other: Observation
37 Completed Phase 2 Study of BA058 Transdermal Delivery in Postmenopausal Women With Osteoporosis
Condition: Post Menopausal Osteoporosis
Interventions: Drug: BA058 Placebo;   Drug: BA058 Transdermal (50 mcg);   Drug: BA058 Transdermal (100 mcg);   Drug: BA058 Transdermal (150 mcg);   Drug: BA058 Injection (80 mcg)
38 Completed Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients
Conditions: Osteoporosis;   Hip Fracture
Intervention: Behavioral: Allied health professional-run osteoporosis service ("case-management")
39 Completed Alendronate and/or Parathyroid Hormone for Osteoporosis
Condition: Osteoporosis
Interventions: Drug: Human parathyroid hormone [hPTH-(1-34)];   Drug: alendronate
40 Completed
Has Results
Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women
Condition: Postmenopausal Osteoporosis
Interventions: Drug: menatetranone;   Drug: alfacalcidol

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years